Karyopharm Therapeutics Income Statement (2012-2025) | KPTI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2012	Dec2012	Mar2013	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue	0.03M	0.03M	0.23M	0.13M	1.25M	0.02M	0.17M	0.02M	0.02M	0.02M	-0.06M	0.15M	0.07M	0.03M		0.06M	0.05M	0.05M	0.07M	0.00M		1.53M	10.00M	19.89M	0.24M	0.21M	0.15M	9.49M	13.15M	18.10M	18.14M	33.51M	21.33M	35.10M	23.26M	22.60M	37.69M	126.27M	47.67M	39.68M	36.15M	33.58M	38.70M	37.58M	36.01M	33.75M	33.13M	42.79M	38.78M	30.54M	30.02M	37.93M	44.04M	34.08M
Cost of Revenue																													1.01M							1.14M	0.59M	0.74M	1.43M	0.94M	0.98M	1.87M	1.35M	1.19M	0.91M	1.49M	1.91M	1.47M	1.30M	1.33M	1.30M	1.05M	2.11M	1.48M
Gross Profit																													12.14M							21.46M	37.10M	125.53M	46.24M	38.74M	35.16M	31.71M	37.35M	36.38M	35.10M	32.26M	31.21M	41.32M	37.48M	29.21M	28.71M	36.88M	41.93M	32.59M
Operating items
Research & Development	3.00M	3.67M	4.96M	6.06M	7.74M	52.84M	10.98M	13.16M	15.95M		20.75M	27.01M	25.92M	24.06M	21.80M	24.58M	19.89M	20.67M	24.08M	23.12M	25.24M	34.83M	41.32M	44.73M	36.43M	38.89M	37.97M	26.52M	26.27M	31.58M	34.00M	42.59M	37.04M	37.19M	37.05M	33.98M	45.81M	44.00M	42.06M	44.31M	31.36M	30.93M	32.34M	31.48M	35.55M	39.38M	35.42M	38.37M	36.13M	33.30M	34.62M	32.79M	30.54M	27.67M
Selling, General & Administrative	0.67M	0.60M	0.88M	0.94M	1.58M	10.82M	2.90M	3.31M	3.81M		5.40M	6.16M	4.76M	5.26M	5.55M	5.96M	5.90M	6.54M	6.26M	6.63M	5.82M	6.15M	7.62M	9.49M	12.97M	18.77M	27.10M	24.66M	25.27M	28.39M	30.68M	30.84M	30.97M	33.93M	37.65M	36.53M	35.10M	34.56M	38.77M	37.34M	34.65M	34.65M	35.91M	34.48M	30.80M	30.69M	29.55M	31.07M	27.63M	27.19M	27.35M	28.48M	26.61M	22.77M
Other Operating Expenses						-51.48M				25.96M																			1.01M	1.39M	0.82M	0.40M	0.44M	1.05M	0.93M	1.14M	0.59M	0.74M	1.43M	0.94M	0.98M	1.87M	1.35M	1.19M	0.91M	1.49M	1.91M	1.47M	1.30M	1.33M	1.30M	1.05M	2.11M	1.48M
Operating Expenses	3.67M	4.27M	5.84M	7.00M	9.32M	12.17M	13.88M	16.47M	19.77M	25.96M	26.15M	33.16M	30.68M	29.33M	27.35M	30.54M	25.79M	27.21M	30.35M	29.75M	31.05M	40.99M	48.94M	54.22M	49.39M	57.66M	65.08M	51.18M	52.55M	61.36M	65.49M	73.83M	68.44M	72.17M	75.63M	71.65M	81.50M	79.31M	82.26M	82.59M	66.98M	67.45M	69.60M	67.15M	67.27M	71.56M	66.89M	70.91M	65.07M	61.82M	63.27M	62.32M	59.26M	51.92M
Operating Income	-3.63M	-4.24M	-5.61M	-6.87M	-9.32M	-12.15M	-13.71M	-16.45M	-19.74M	-25.94M	-26.15M	-33.01M	-30.61M	-29.30M	-27.35M	-30.48M	-25.74M	-27.16M	-30.28M	-29.75M	-31.05M	-39.45M	-38.94M	-34.33M	-49.15M	-57.45M	-64.92M	-41.69M	-39.40M	-43.27M	-47.36M	-40.32M	-47.11M	-37.07M	-52.37M	-49.05M	-43.81M	46.96M	-34.59M	-42.91M	-30.84M	-33.87M	-30.90M	-29.57M	-31.26M	-37.81M	-33.76M	-28.12M	-26.28M	-31.28M	-33.26M	-24.39M	-15.22M	-17.84M
EBIT	-3.63M	-4.24M	-5.61M	-6.87M	-9.32M	-12.15M	-13.71M	-16.45M	-19.74M	-25.94M	-26.15M	-33.01M	-30.61M	-29.30M	-27.35M	-30.48M	-25.74M	-27.16M	-30.28M	-29.75M	-31.05M	-39.45M	-38.94M	-34.33M	-49.15M	-57.45M	-64.92M	-41.69M	-39.40M	-43.27M	-47.36M	-40.32M	-47.11M	-37.07M	-52.37M	-49.05M	-43.81M	46.96M	-34.59M	-42.91M	-30.84M	-33.87M	-30.90M	-29.57M	-31.26M	-37.81M	-33.76M	-28.12M	-26.28M	-31.28M	-33.26M	-24.39M	-15.22M	-17.84M
Non-operating items
Interest & Investment Income					0.00M	0.01M	0.02M	0.02M	0.02M		0.14M	0.27M	0.24M	0.25M	0.29M	0.33M	0.31M	0.36M	0.40M	0.41M	0.45M	0.43M	0.51M	0.65M	1.10M	1.77M	1.77M	1.41M	1.14M	1.10M	0.97M	0.85M	0.60M	0.40M	0.26M	0.17M	0.10M	0.06M	0.07M	0.29M	0.66M	1.33M	2.85M	2.82M	2.75M	2.52M	2.16M	1.93M	1.83M	1.48M	1.00M	0.61M	0.55M	0.61M
Other Non Operating Income				0.00M		0.00M	0.02M	0.02M	0.02M	0.01M	0.08M	0.32M	0.24M	0.26M	0.00M	0.32M	0.32M	0.37M	-0.01M	-0.03M	-0.03M	0.42M	-0.01M	0.01M	-0.01M	-0.76M	-0.00M	-0.04M	0.01M	-0.01M	0.03M	-0.06M	-0.14M	0.38M	-0.06M	0.44M	0.02M	-0.48M	-0.07M	-0.01M	0.02M	-0.01M	-0.26M	0.03M	0.09M	-0.21M	0.20M	44.70M	3.79M		19.82M	-2.21M	-7.42M	-72.56M
Non Operating Income				0.00M		0.00M	0.02M	0.02M	0.02M	0.01M	0.08M	0.32M	0.24M	0.26M	0.29M	0.32M	0.32M	0.37M	0.39M	0.38M	0.43M	0.42M	0.49M	0.66M	1.08M	-0.76M	-1.23M	-1.72M	-1.95M	-5.38M	-5.51M	-5.97M	-6.34M	-6.29M	-4.89M	-4.40M	-7.89M	-8.36M	-6.68M	-6.03M	-5.44M	-4.56M	-3.17M	-2.93M	-3.23M	-3.90M	-3.53M	51.98M	-5.76M	0.39M	19.82M	-12.82M	-17.87M	-84.42M
Net income details
EBT	-3.63M	-4.24M	-5.61M	-6.87M	-9.13M	-12.33M	-13.69M	-16.43M	-19.72M	-25.94M	-26.07M	-32.70M	-30.37M	-29.05M	-27.06M	-30.16M	-25.43M	-26.80M	-29.89M	-29.37M	-30.63M	-39.03M	-38.45M	-33.67M	-48.07M	-58.19M	-66.15M	-43.41M	-41.35M	-48.65M	-52.87M	-46.29M	-53.45M	-43.36M	-57.27M	-53.45M	-51.71M	38.60M	-41.27M	-48.94M	-36.28M	-39.33M	-34.07M	-32.50M	-34.49M	-41.95M	-37.29M	23.86M	-32.04M	-30.97M	-23.43M	-37.21M	-33.09M	-102.27M
Tax Provisions																			0.02M	0.02M	0.01M	0.01M	0.01M	-0.02M	0.01M	0.02M	0.01M	0.01M	0.02M	0.00M	0.07M	0.14M	0.04M	0.06M	0.15M	0.13M	0.11M	-0.09M	0.13M	0.12M	0.04M	0.10M	0.05M	0.13M	0.01M	0.13M	0.07M	0.07M	0.03M	-0.11M	0.04M	0.04M	0.03M	-0.07M
Profit After Tax	-3.63M	-4.24M	-5.61M	-6.87M	-50.42M	16.48M	-13.69M	-16.43M	-19.72M	-25.93M	-26.07M	-32.70M	-30.37M	-29.05M	-27.06M	-30.16M	-25.43M	-26.93M	-29.92M	-29.39M	-30.64M	-39.04M	-38.46M	-33.66M	-48.08M	-58.21M	-66.16M	-43.41M	-41.37M	-48.65M	-52.93M	-46.43M	-53.49M	-43.42M	-57.41M	-53.58M	-51.81M	38.72M	-41.40M	-49.06M	-36.32M	-38.51M	-34.13M	-32.63M	-34.51M	-41.84M	-37.36M	23.79M	-32.07M	-30.78M	-23.46M	-37.25M	-33.13M	-102.20M
Income from Continuing Operations	-3.63M	-4.24M	-5.61M	-6.87M	-9.13M	-12.33M	-13.69M	-16.43M	-19.72M	-25.94M	-26.07M	-32.70M	-30.37M	-29.05M	-27.06M	-30.16M	-25.43M	-26.80M	-29.92M	-29.39M	-30.64M	-39.04M	-38.46M	-33.66M	-48.08M	-58.21M	-66.16M	-43.41M	-41.37M	-48.65M	-52.93M	-46.43M	-53.49M	-43.42M	-57.41M	-53.58M	-51.81M	38.69M	-41.40M	-49.06M	-36.32M	-39.43M	-34.13M	-32.63M	-34.51M	-42.08M	-37.36M	23.79M	-32.07M	-30.86M	-23.46M	-37.25M	-33.13M	-102.20M
Consolidated Net Income	-3.63M	-4.24M	-5.61M	-6.87M	-9.13M	-12.33M	-13.69M	-16.43M	-19.72M	-25.94M	-26.07M	-32.70M	-30.37M	-29.05M	-27.06M	-30.16M	-25.43M	-26.80M	-29.92M	-29.39M	-30.64M	-39.04M	-38.46M	-33.66M	-48.08M	-58.21M	-66.16M	-43.41M	-41.37M	-48.65M	-52.93M	-46.43M	-53.49M	-43.42M	-57.41M	-53.58M	-51.81M	38.69M	-41.40M	-49.06M	-36.32M	-39.43M	-34.13M	-32.63M	-34.51M	-42.08M	-37.36M	23.79M	-32.07M	-30.86M	-23.46M	-37.25M	-33.13M	-102.20M
Income towards Parent Company	-3.63M	-4.24M	-5.61M	-6.87M	-9.13M	-12.33M	-13.69M	-16.43M	-19.72M	-25.94M	-26.07M	-32.70M	-30.37M	-29.05M	-27.06M	-30.16M	-25.43M	-26.80M	-29.92M	-29.39M	-30.64M	-39.04M	-38.46M	-33.66M	-48.08M	-58.21M	-66.16M	-43.41M	-41.37M	-48.65M	-52.93M	-46.43M	-53.49M	-43.42M	-57.41M	-53.58M	-51.81M	38.69M	-41.40M	-49.06M	-36.32M	-39.43M	-34.13M	-32.63M	-34.51M	-42.08M	-37.36M	23.79M	-32.07M	-30.86M	-23.46M	-37.25M	-33.13M	-102.20M
Net Income towards Common Stockholders	-3.63M	-4.24M	-5.61M	-6.87M	-9.32M	-12.15M	-13.69M	-16.43M	-19.72M	-25.93M	-26.07M	-32.70M	-30.37M	-29.05M	-27.06M	-30.16M	-25.43M	-26.80M	-29.92M	-29.39M	-30.64M	-39.04M	-38.46M	-33.66M	-48.08M	-58.21M	-66.16M	-43.41M	-41.37M	-48.65M	-52.93M	-46.43M	-53.49M	-43.42M	-57.41M	-53.58M	-51.81M	38.69M	-41.40M	-49.06M	-36.32M	-39.43M	-34.13M	-32.63M	-34.51M	-42.08M	-37.36M	23.79M	-32.07M	-30.86M	-23.46M	-37.25M	-33.13M	-102.20M
Additional items
EPS (Basic)	-1.97	-2.39	-2.52	-2.86	-3.66	-2.00	-0.46	-0.55	-0.61	-0.83	-0.74	-0.92	-0.85	-0.82	-0.75	-0.84	-0.69	-0.71	-0.71	-0.64	-0.65	-0.85	-0.78	-0.60	-0.79	-0.96	-1.09	-0.71	-0.67	-0.76	-0.78	-0.63	-0.73	-0.58	-0.77	-0.71	-0.69	0.52	-0.53	-0.62	-0.45	-0.42	-0.30	-0.29	-0.30	-17.90	-4.85	2.26	-3.85	-3.73	-2.77	-4.32	-3.82	-7.00
EPS (Weighted Average and Diluted)																																		-0.60		-0.71	-0.69	0.52	-0.53	-0.62	-0.45	-0.42	-0.30	-0.29	-0.30	-17.90	-4.85	-2.97	-3.85	-3.60	-2.77	-4.32	-3.82	-7.00
Shares Outstanding (Weighted Average)	-6.96	1.78M	2.23M	2.40M	2.54M	6.07M	29.61M	29.66M	32.56M	31.14M	35.32M	35.70M	35.71M	35.62M	35.88M	35.96M	36.82M	37.52M	41.89M	45.83M	47.14M	45.90M	49.60M							61.95M	0.07M	73.24M	73.47M	72.04M	74.52M	75.19M	75.46M	75.22M	77.57M	79.65M	80.21M	81.87M	113.48M	114.21M	114.40M	114.22M	0.01M	121.03M			0.01M
Shares Outstanding (Diluted Average)																																		72.04M		75.19M	75.46M	75.22M	77.57M	79.65M	80.21M	81.87M	113.48M	114.21M	114.40M	114.22M	0.01M	154.43M			0.01M
EBITDA	-3.63M	-4.24M	-5.61M	-6.87M	-9.32M	-12.15M	-13.69M	-16.43M	-19.72M	-25.94M	-26.15M	-33.01M	-30.61M	-29.30M	-27.35M	-30.48M	-25.74M	-27.16M	-30.28M	-29.75M	-31.05M	-39.45M	-38.94M	-34.33M	-49.15M	-57.45M	-64.92M	-41.69M	-39.40M	-43.27M	-47.36M	-40.32M	-47.11M	-37.07M	-52.37M	-49.05M	-43.81M	46.96M	-34.59M	-42.91M	-30.84M	-33.87M	-30.90M	-29.57M	-31.26M	-37.81M	-33.76M	-28.12M	-26.28M	-31.28M	-33.26M	-24.39M	-15.22M	-17.84M
Interest Expenses					-0.19M	0.19M					0.06M	-0.05M															3.00M	3.09M	3.09M	6.47M	6.51M	6.76M	6.80M	7.07M	5.09M	5.00M	8.01M	7.94M	6.68M	6.31M	6.11M	5.88M	5.76M	5.78M	6.07M	6.21M	5.88M	8.95M	11.38M	11.20M	10.99M	11.23M	11.01M	12.62M
Tax Rate																			-0.08%	-0.06%	-0.04%	-0.02%	-0.03%	0.05%	-0.03%	-0.03%	-0.02%	-0.02%	-0.05%	0.00%	-0.12%	-0.30%	-0.08%	-0.14%	-0.26%	-0.25%	-0.21%	-0.23%	-0.32%	-0.25%	-0.12%	-0.26%	-0.16%	-0.39%	-0.03%	-0.31%	-0.19%	0.28%	-0.09%	0.35%	-0.15%	-0.11%	-0.10%	0.07%

Research Tools

Karyopharm Therapeutics Income Statement (2012-2025) | KPTI

Create an account

Sign In

Reset Password